The opportunity is not in buying every low-priced penny stock but rather in finding smaller companies where earnings, balance ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. | Chris ...

Recursion Pharmaceuticals (RXRX) is back in focus after management detailed AI driven gains in drug discovery, including 25 new targets identified at once, as investors look ahead to an earnings ...

Project Hail Mary author Andy Weir keeps on recommending this sci-fi book everywhere he goes, and it's not hard to understand ...

The Internet Corporation for Assigned Names and Numbers (ICANN) today announced that it is planning to change the trust anchor for the Domain Name System (DNS) on 11 October 2026. This change, known ...

At 25, Kurt Gödel proved there can never be a mathematical “theory of everything.” Columnist Natalie Wolchover explores the ...

People are starting to emulate AI as to how they think AI thinks. But this is quite problematic. An AI Insider analysis and ...

Feedback has learned that, according to reports, Meta is building an AI version of Mark Zuckerberg to interact with staff. Feedback hopes this doesn't become a trend ...

Silicon Valley oligarchs worried about the risks their technology posed to the world. They forgot about people.

Now we have a new threat, and the anxiety feels familiar because, well it is familiar. The names change, but to me the moral ...

Ineffable Intelligence, a British AI lab founded a mere few months ago by former DeepMind researcher David Silver, has raised $1.1 billion in funding at a valuation of $5.1 billion.

Former employees at AI giants are raising hundreds of millions of dollars from investors months on from launching.